A wholly owned subsidiary of Anhui Biochem Pharmaceutical, a high-tech enterprise specializing in the research, development, production and sale of chemical drugs for antiviral treatment of diseases such as AIDS and hepatitis B. The company holds 23 drug registration certificates for chemical formulations treating AIDS, hepatitis B and other diseases, with more than 20 additional formulations under development awaiting registration approval.

No comments available.
Leave your rating & comment